Christopher R Czajka
Visit Investigator ProfileInvestigation Details
Ian J Thomson , Santos E Camara , Daniel A Congdon , Devon M Shoop , Roger F Zabinski , Lisa T Michel , Nancy E Byerly , Jeffrey J Leclair , Marcus F Yambot , Andrew K Haack , Crystal A Harlan , Leon R Marquart , Jinkee M Vila Binayug , Gary C Pecie , Gary C Pecic , Binh T Nguyen , Vanessa Y Gelsey , Jessica B Clark , Bruce R Burrell , Yi Wang , Nathaniel B Phillips-Sylvain , Eileen A Liu , Michael R Shanks , Gerard P De Leon , Mark W Babbitt , Alicia K Mckinsey , Jeffrey N Gerdes
Detailed Analysis
Christopher R Czajka focuses on meticulously assessing the cleanliness and aseptic conditions in production areas. He also places high importance on laboratory testing and containment procedures to ensure the quality and safety of drug products.
Christopher R Czajka tends to focus on aseptic processing areas, containment procedures, cleanliness, and laboratory testing. He prioritizes ensuring the proper procedures for aseptic production and conformance testing to maintain the quality of drug products.
- Contamination Control
- Facility Design
- Cleaning Validation
- Sample Testing
- Environmental Monitoring
Unlock Insights from 483s & Stay Audit Ready with FDA Tracker
Monitor FDA Six Systems, Analyse 483s with Observations, Investigators & Companies